News Jun 16, 2022

网曝吃瓜黑料一区二区三区 Chosen by Spark Therapeutics to Build Gene Therapy Innovation Center

Cutting-edge Philadelphia facility to deliver life-impacting products

Laboratory glassware containing chemical liquid, science research, science background

网曝吃瓜黑料一区二区三区 was awarded an engineering, procurement and construction management contract with Spark Therapeutics, Inc. (Spark) to build its Gene Therapy Innovation Center in the University City area of West Philadelphia. When complete, the multi-story facility will serve as a global center of excellence for gene therapy manufacturing and advance the science of gene therapy.   

According to Spark, the first phase of the project includes an initial investment of $575 million, and the anticipated 500,000 square foot facility nearly doubles the company鈥檚 physical footprint in Philadelphia. The facility is estimated to be completed in 2026.

鈥淥ur goal is to build an innovative facility that supports Spark鈥檚 mission to drive science forward,鈥 says 网曝吃瓜黑料一区二区三区 Advanced Facilities Senior Vice President Koti Vadlamudi. 鈥淚t will also be the first gene therapy manufacturing facility of its size in Philadelphia. We stand ready to support Spark鈥檚 vision of a world where no life is limited by genetic disease.鈥 

网曝吃瓜黑料一区二区三区 has provided solutions for more than 30 clients in the cell and gene therapy market on projects involving full-scale launch and production facilities with multiple modalities.